Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine. (Q51010247)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 1996

Language	Label	Description	Also known as
English	Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine.	scientific article published in September 1996

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

author name string

I Papadopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

P Rudolph

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

K Weichert-Jacobsen

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

O Thiemann

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

D Papadopoulou

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

language of work or name

0 references

publication date

1 September 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

48

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

373-378

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA content, nuclear grading and early tumor progression in renal cell cancer: a prospective study on frozen specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA content and the proliferation marker Ki-67 as prognostic indicators in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA analysis in hepatoblastoma by flow and image cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

[DNA measurement of malignant tumors by impulse cytophotometry. The principles and importance for assessing growth behavior and the degree of abnormality]

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(96)00168-9

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8804488

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51010247&oldid=1395282120"